These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 196791

  • 1. Measurement of the apoproteins of human serum lipoproteins by rocket immunoelectrophoresis.
    Onitiri AC, Lewis B.
    Clin Chim Acta; 1977 Aug 15; 79(1):39-45. PubMed ID: 196791
    [Abstract] [Full Text] [Related]

  • 2. Comparative serum apolipoprotein studies in ischaemic heart disease and control subjects.
    Onitiri AC, Jover E.
    Clin Chim Acta; 1980 Nov 20; 108(1):25-30. PubMed ID: 7470245
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
    Ericsson M, Johnson O, Tollin C, Furberg B, Backman C, Angquist K.
    Scand J Rehabil Med; 1982 Nov 20; 14(4):209-12. PubMed ID: 7178868
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
    Angquist KA, Johnson O, Ericsson M, Tollin C.
    Acta Chir Scand; 1982 Nov 20; 148(8):675-8. PubMed ID: 6820598
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correlations between intravenous fat tolerance and serum lipoproteins in normal and atherosclerotic subjects.
    Ericsson M, Rössner S.
    Atherosclerosis; 1979 May 20; 33(1):89-97. PubMed ID: 223603
    [No Abstract] [Full Text] [Related]

  • 12. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study.
    Lopes-Virella MF, Wohltmann HJ, Mayfield RK, Loadholt CB, Colwell JA.
    Diabetes; 1983 Jan 20; 32(1):20-5. PubMed ID: 6336700
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB.
    Am J Med; 1979 Feb 20; 66(2):303-10. PubMed ID: 218451
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreased removal of triglycerides from the blood--a mechanism for the hypertriglyceridemia in male patients with coronary artery disease.
    Tollin C, Ericsson M, Johnson O, Backman C, Jacobsson KA, Osterman G, Billström A.
    Int J Cardiol; 1984 Feb 20; 5(2):185-94. PubMed ID: 6365804
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.